Cash Flow Statement

Amortization of Deferred Charges Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Other financing activities Preferred Shares Issued Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Crinetics Pharmaceuticals (CRNX) Change in Acquisitions & Divestments: 2019-2025